Filing Details

Accession Number:
0001209191-19-011160
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-19 17:02:51
Reporting Period:
2019-02-14
Accepted Time:
2019-02-19 17:02:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Biological Products, (No Disgnostic Substances) (2836) 510596811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559827 Jr. A. Anthony Florence 5425 Wisconsin Avenue
Suite 800
Chevy Chase MD 20815
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-14 9,948,269 $0.47 34,948,269 No 4 P Indirect See Note 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 2
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2019-02-14 2,487,067 $0.13 2,487,067 $0.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,487,067 2019-02-14 2024-02-14 No 4 P Indirect
Footnotes
  1. Acquired from the issuer pursuant to a Subscription Agreement dated February 11, 2019, with a closing date of February 14, 2019.
  2. The Reporting Person is a manager of NEA 16 GP, LLC, ("NEA 16 GP") which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest.